Black Diamond Therapeutics
Biotechnology, 1 Main St, Cambridge, Massachusetts, 02142, United States, 51-200 Employees
Who is BLACK DIAMOND THERAPEUTICS
Black Diamond Therapeutics is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations, expanding the addressable patient population by...
Read More
-
Headquarters: 1 Main St, Cambridge, Massachusetts, 02142, United States
-
Date Founded: 2017
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from BLACK DIAMOND THERAPEUTICS
Black Diamond Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Black Diamond Therapeutics
Answer: Black Diamond Therapeutics's headquarters are located at 1 Main St, Cambridge, Massachusetts, 02142, United States
Answer: Black Diamond Therapeutics's official website is https://blackdiamondtherapeutics.com
Answer: Black Diamond Therapeutics's revenue is $10 Million to $25 Million
Answer: Black Diamond Therapeutics's SIC: 2834
Answer: Black Diamond Therapeutics has 51-200 employees
Answer: Black Diamond Therapeutics is in Biotechnology
Answer: Black Diamond Therapeutics contact info: Phone number: Website: https://blackdiamondtherapeutics.com
Answer: Black Diamond Therapeutics is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations, expanding the addressable patient population by offering one solution for many mutations. Our mission: defeat cancer resistance and provide people living with cancer the opportunity to experience longer, healthier and more active lives. We are advancing two potent, brain-penetrant clinical-stage programs: BDTX-1535, a fourth-generation EGFR inhibitor targeting non-small cell lung cancer (NSCLC) and glioblastoma (GBM) and BDTX-4933, a RAF inhibitor targeting KRAS, NRAS and BRAF alterations in NSCLC and other solid tumors.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month